Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial

DIAMOND study group

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Fingerprint Dive into the research topics of 'Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial'. Together they form a unique fingerprint.

Medicine & Life Sciences